Literature DB >> 32787142

Exploration of Alternative Scaffolds for P2Y14 Receptor Antagonists Containing a Biaryl Core.

Young-Hwan Jung1, Jinha Yu1, Zhiwei Wen1, Veronica Salmaso1, Tadeusz P Karcz2,3, Ngan B Phung1, Zhoumou Chen4, Sierra Duca1, John M Bennett1, Steven Dudas1, Daniela Salvemini4, Zhan-Guo Gao1, Donald N Cook2, Kenneth A Jacobson1.   

Abstract

Various heteroaryl and bicyclo-aliphatic analogues of zwitterionic biaryl n class="Gene">P2Y14 receptor (P2Y14R) antagonists were synthesized, and affinity was measured in P2Y14R-expressing Chinese hamster ovary cells by flow cytometry. Given this series' low water solubility, various polyethylene glycol derivatives of the distally binding piperidin-4-yl moiety of moderate affinity were synthesized. Rotation of previously identified 1,2,3-triazole attached to the central m-benzoic acid core (25) provided moderate affinity but not indole and benzimidazole substitution of the aryl-triazole. The corresponding P2Y14R region is predicted by homology modeling as a deep, sterically limited hydrophobic pocket, with the outward pointing piperidine moiety being the most flexible. Bicyclic-substituted piperidine ring derivatives of naphthalene antagonist 1, e.g., quinuclidine 17 (MRS4608, IC50 ≈ 20 nM at hP2Y14R/mP2Y14R), or of triazole 2, preserved affinity. Potent antagonists 1, 7a, 17, and 23 (10 mg/kg) protected in an ovalbumin/Aspergillus mouse asthma model, and PEG conjugate 12 reduced chronic pain. Thus, we expanded P2Y14R antagonist structure-activity relationship, introducing diverse physical-chemical properties.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32787142      PMCID: PMC8040948          DOI: 10.1021/acs.jmedchem.0c00745

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  49 in total

1.  GPR105 ablation prevents inflammation and improves insulin sensitivity in mice with diet-induced obesity.

Authors:  Jianfeng Xu; Hidetaka Morinaga; Dayoung Oh; Pingping Li; Ai Chen; Saswata Talukdar; Yaël Mamane; Joseph A Mancini; Andrea R Nawrocki; Eduardo Lazarowski; Jerrold M Olefsky; Jane J Kim
Journal:  J Immunol       Date:  2012-07-09       Impact factor: 5.422

2.  OPLS3: A Force Field Providing Broad Coverage of Drug-like Small Molecules and Proteins.

Authors:  Edward Harder; Wolfgang Damm; Jon Maple; Chuanjie Wu; Mark Reboul; Jin Yu Xiang; Lingle Wang; Dmitry Lupyan; Markus K Dahlgren; Jennifer L Knight; Joseph W Kaus; David S Cerutti; Goran Krilov; William L Jorgensen; Robert Abel; Richard A Friesner
Journal:  J Chem Theory Comput       Date:  2015-12-01       Impact factor: 6.006

3.  New substructure filters for removal of pan assay interference compounds (PAINS) from screening libraries and for their exclusion in bioassays.

Authors:  Jonathan B Baell; Georgina A Holloway
Journal:  J Med Chem       Date:  2010-04-08       Impact factor: 7.446

Review 4.  UDP-Sugars as Extracellular Signaling Molecules: Cellular and Physiologic Consequences of P2Y14 Receptor Activation.

Authors:  Eduardo R Lazarowski; T Kendall Harden
Journal:  Mol Pharmacol       Date:  2015-03-31       Impact factor: 4.436

Review 5.  Polypharmacology of conformationally locked methanocarba nucleosides.

Authors:  Kenneth A Jacobson; Dilip K Tosh; Kiran S Toti; Antonella Ciancetta
Journal:  Drug Discov Today       Date:  2017-08-03       Impact factor: 7.851

6.  The G protein-coupled receptor P2Y14 influences insulin release and smooth muscle function in mice.

Authors:  Jaroslawna Meister; Diana Le Duc; Albert Ricken; Ralph Burkhardt; Joachim Thiery; Helga Pfannkuche; Tobias Polte; Johannes Grosse; Torsten Schöneberg; Angela Schulz
Journal:  J Biol Chem       Date:  2014-07-03       Impact factor: 5.157

7.  Discovery of diarylurea P2Y(1) antagonists with improved aqueous solubility.

Authors:  Tammy C Wang; Jennifer X Qiao; Charles G Clark; Ji Jua; Laura A Price; Qimin Wu; Ming Chang; Joanna Zheng; Christine S Huang; Gerry Everlof; William A Schumacher; Pancras C Wong; Dietmar A Seiffert; Anne B Stewart; Jeffrey S Bostwick; Earl J Crain; Carol A Watson; Robert Rehfuss; Ruth R Wexler; Patrick Y S Lam
Journal:  Bioorg Med Chem Lett       Date:  2013-04-06       Impact factor: 2.823

8.  UDP-glucose acting at P2Y14 receptors is a mediator of mast cell degranulation.

Authors:  Zhan-Guo Gao; Yi Ding; Kenneth A Jacobson
Journal:  Biochem Pharmacol       Date:  2009-11-05       Impact factor: 5.858

9.  Lowering Lipophilicity by Adding Carbon: One-Carbon Bridges of Morpholines and Piperazines.

Authors:  Sébastien L Degorce; Michael S Bodnarchuk; Iain A Cumming; James S Scott
Journal:  J Med Chem       Date:  2018-09-20       Impact factor: 7.446

10.  pkCSM: Predicting Small-Molecule Pharmacokinetic and Toxicity Properties Using Graph-Based Signatures.

Authors:  Douglas E V Pires; Tom L Blundell; David B Ascher
Journal:  J Med Chem       Date:  2015-04-22       Impact factor: 7.446

View more
  7 in total

Review 1.  Adipocyte purinergic receptors activated by uracil nucleotides as obesity and type 2 diabetes targets.

Authors:  Shanu Jain; Kenneth A Jacobson
Journal:  Curr Opin Pharmacol       Date:  2022-02-26       Impact factor: 5.547

Review 2.  Purinergic Signaling in Liver Pathophysiology.

Authors:  Shanu Jain; Kenneth A Jacobson
Journal:  Front Endocrinol (Lausanne)       Date:  2021-08-11       Impact factor: 5.555

Review 3.  Purinergic GPCR transmembrane residues involved in ligand recognition and dimerization.

Authors:  Veronica Salmaso; Shanu Jain; Kenneth A Jacobson
Journal:  Methods Cell Biol       Date:  2021-07-12       Impact factor: 1.829

4.  Structure-Activity Relationship of Heterocyclic P2Y14 Receptor Antagonists: Removal of the Zwitterionic Character with Piperidine Bioisosteres.

Authors:  Young-Hwan Jung; Veronica Salmaso; Zhiwei Wen; John M Bennett; Ngan B Phung; David I Lieberman; Varun Gopinatth; John C R Randle; Zhoumou Chen; Daniela Salvemini; Tadeusz P Karcz; Donald N Cook; Kenneth A Jacobson
Journal:  J Med Chem       Date:  2021-03-31       Impact factor: 7.446

Review 5.  Purinergic signaling in diabetes and metabolism.

Authors:  Shanu Jain; Kenneth A Jacobson
Journal:  Biochem Pharmacol       Date:  2020-12-25       Impact factor: 5.858

6.  Bridged Piperidine Analogues of a High Affinity Naphthalene-Based P2Y14R Antagonist.

Authors:  Zhiwei Wen; Veronica Salmaso; Young-Hwan Jung; Ngan B Phung; Varun Gopinatth; Qasim Shah; Alexandra T Patterson; John C R Randle; Zhoumou Chen; Daniela Salvemini; David I Lieberman; Gregory S Whitehead; Tadeusz P Karcz; Donald N Cook; Kenneth A Jacobson
Journal:  J Med Chem       Date:  2022-02-03       Impact factor: 7.446

Review 7.  Purinergic Signaling: Impact of GPCR Structures on Rational Drug Design.

Authors:  Veronica Salmaso; Kenneth A Jacobson
Journal:  ChemMedChem       Date:  2020-09-18       Impact factor: 3.540

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.